Autoliv Inc., operating through two principal subsidiaries Autoliv AB and Autoliv ASP, is one of the leading manufacturers and suppliers of a wide range of products, which majorly includes passive safety systems. Its passive safety systems include modules and components for frontal-impact & side-impact airbag protection systems, seatbelts, steering wheels, inflator technologies, battery cable cutters, pedestrian protection systems and child seats. Autoliv engages in joint ventures to expand geographical expansion, develop and gain support to market its full product line to vehicle manufacturers. Its business is conducted in five key regions, which includes Europe, the Americas, China, Japan and the Rest of Asia.'Major customers of this automotive safety supplier include Mitsubishi Motors, Nissan, Renault, Ford, Volkswagen, Hyundai, Kia, Honda, Toyota, Daimler, General Motors, BMW and Stellantis. It has two reportable segments: Airbags & Associated Products'and Seatbelts & Associated Products....
+See More2017-12-19 09:39:00 Tuesday ET
From Oprah Winfrey to Bill Gates, this infographic visualization summarizes the key habits and investment styles of highly successful entrepreneurs:
2017-05-25 08:35:00 Thursday ET
Treasury Secretary Steve Mnuchin has released a 147-page report on financial deregulation under the Trump administration. This financial deregulation seeks
2018-12-01 11:37:00 Saturday ET
As the solo author of the books Millionaire Next Door and Richer Than Millionaire, William Danko shares 3 top secrets for *better wealth creation*. True pro
2018-05-07 07:32:00 Monday ET
President Trump seeks to honor his campaign promise of lower U.S. medical costs by forcing higher big-pharma prices in foreign countries such as Canada, Bri
2019-12-25 19:46:00 Wednesday ET
Former White House chief economic advisor Nouriel Roubini discusses the major limits of central-bank-driven fiscal deficits. The International Monetary Fund
2025-10-31 12:26:00 Friday ET
With respect to wider weight loss treatment and obesity treatment, the global market for GLP-1 medications now grows substantially to benefit more than 1 bi